Everhart Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Sell
19,484
-490
-2% -$57.4K 0.16% 66
2026
Q1
$2.4M Buy
19,974
+4,823
+32% +$557K 0.2% 64
2025
Q4
$1.59M Buy
15,151
+2,965
+24% +$278K 0.15% 89
2025
Q3
$1.02M Buy
12,186
+321
+3% +$26.4K 0.1% 138
2025
Q2
$939K Sell
11,865
-1,945
-14% -$155K 0.11% 127
2025
Q1
$1.24M Buy
13,810
+3,224
+30% +$301K 0.17% 87
2024
Q4
$1.05M Sell
10,586
-1,464
-12% -$151K 0.22% 92
2024
Q3
$1.37M Sell
12,050
-823
-6% -$97.8K 0.3% 61
2024
Q2
$1.59M Buy
12,873
+1,355
+12% +$175K 0.41% 43
2024
Q1
$1.52M Buy
11,518
+2,210
+24% +$272K 0.44% 41
2023
Q4
$1.01M Sell
9,308
-732
-7% -$76K 0.36% 57
2023
Q3
$1.03M Buy
10,040
+452
+5% +$48.7K 0.44% 50
2023
Q2
$1.11M Buy
9,588
+586
+7% +$66.5K 0.46% 43
2023
Q1
$958K Buy
9,002
+900
+11% +$97.2K 0.43% 49
2022
Q4
$899K Buy
8,102
+1,200
+17% +$123K 0.45% 45
2022
Q3
$594K Buy
6,902
+812
+13% +$72.5K 0.33% 61
2022
Q2
$556K Buy
6,090
+3,572
+142% +$317K 0.34% 66
2022
Q1
$207K Buy
+2,518
New +$199K 0.12% 127

Other funds holding MRK

Everhart Financial Group's MRK Position: Q2 2026 in Review

Everhart Financial Group reduced its Merck (MRK) stake by 2.5% in Q2 2026, selling an estimated $57.4K and leaving 19,484 shares worth $2.5M. The position accounts for 0.16% of the portfolio, ranked #66.

Everhart Financial Group first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. 718 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Everhart Financial Group held 19,484 shares of Merck worth $2.5M as of Q2 2026.
  • Everhart Financial Group sold 490 Merck shares in Q2 2026, an estimated $57.4K.
  • Merck made up 0.16% of Everhart Financial Group's portfolio in Q2 2026, its #66 holding.
  • Everhart Financial Group first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • 718 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.